230 related articles for article (PubMed ID: 3822285)
1. Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma.
Burke TW; Hoskins WJ; Heller PB; Shen MC; Weiser EB; Park RC
Obstet Gynecol; 1987 Mar; 69(3 Pt 1):382-5. PubMed ID: 3822285
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma.
Ijaz T; Eifel PJ; Burke T; Oswald MJ
Gynecol Oncol; 1998 Aug; 70(2):241-6. PubMed ID: 9740698
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
[TBL] [Abstract][Full Text] [Related]
4. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy.
Coleman RL; Keeney ED; Freedman RS; Burke TW; Eifel PJ; Rutledge FN
Gynecol Oncol; 1994 Oct; 55(1):29-35. PubMed ID: 7959262
[TBL] [Abstract][Full Text] [Related]
5. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
[TBL] [Abstract][Full Text] [Related]
6. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy.
Kodama J; Seki N; Masahiro S; Kusumoto T; Nakamura K; Hongo A; Hiramatsu Y
J Surg Oncol; 2010 Apr; 101(5):413-7. PubMed ID: 20127891
[TBL] [Abstract][Full Text] [Related]
8. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
[TBL] [Abstract][Full Text] [Related]
9. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy.
Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M
Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193
[TBL] [Abstract][Full Text] [Related]
10. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
[TBL] [Abstract][Full Text] [Related]
11. Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: role of adjuvant radiotherapy.
Larson DM; Stringer CA; Copeland LJ; Gershenson DM; Malone JM; Rutledge FN
Obstet Gynecol; 1987 Mar; 69(3 Pt 1):378-81. PubMed ID: 3103034
[TBL] [Abstract][Full Text] [Related]
12. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
[TBL] [Abstract][Full Text] [Related]
13. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
[TBL] [Abstract][Full Text] [Related]
14. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study.
Rotman M; Sedlis A; Piedmonte MR; Bundy B; Lentz SS; Muderspach LI; Zaino RJ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):169-76. PubMed ID: 16427212
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors associated with recurrence in stage IB cervical carcinoma after radical hysterectomy and pelvic lymphadenectomy.
Wilailak S; Tangtrakul S; Srisupundit S; Bullangpoti S; Linasmita V; Bhamarapravati Y
J Med Assoc Thai; 1993 Jan; 76 Suppl 1():74-7. PubMed ID: 8113662
[TBL] [Abstract][Full Text] [Related]
17. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
18. Blood transfusion and the risk of recurrence in stage IB cervical cancer.
Morris PC; Haugen J; Tomjack J; Anderson B; Buller RE
Gynecol Oncol; 1995 Jun; 57(3):401-6. PubMed ID: 7774845
[TBL] [Abstract][Full Text] [Related]
19. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
